Skip to main content

Table 4 Management and outcome

From: The Acute Chest Syndrome in Cameroonian children living with sickle cell disease

  Number (N = 21) Percentage (%)
Antibiotherapy   
Beta-lactam   
 Ceftriaxone (IV: 50 mg/kg/day) 10 47.6
 Ampicillin (IV: 50 mg/kg/8 h) 11 52.4
 Gentamicin (IV: 3 mg/kg/day) 16 76.2
 Azithromycin (oral: 5-10 mg/kg/day) 21 100
Adjuvant therapy   
 Tramadol (IV: 1–2 mg/kg/6 h) 9 42.9
 Paracetamol (oral or IV: 15 mg/kg/6 h) 21 100
 Ibuprofen (oral: 10 mg/kg/8 h) 5 23.8
 Hyperhydration (2.5–3 l/m2 BSa) 21 100
Anti-malarial treatment   
 No 7 33.3
 Yes 14 66.7
Oxygen therapy   
 No 14 66.7
 Yes 7 33.3
Transfusion   
 No 7 33.3
 Yes 14 66.7
Death   
 Yes 1 4.8
 No 20 95.2
Duration of hospitalization   
  ≤ 5 days 8 38.1
  > 5 days 13 61.9
  1. aBS = Body surface; IV = intravenous